Blanket Purchase Agreement V797D70066-36C25725A0012

This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company that provides molecular diagnostic services. The BPA, issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services, has a ceiling value of $320,000 and a period of performance through January 9, 2030.

Under this BPA, Mdxhealth will provide Oncotype DX genomic prostate testing services to the Big Spring VA facility, with a specific task order valued at $9,696.96 and a period of performance through February 2, 2026. This testing supports quality healthcare for veterans across the VA's national network by leveraging Mdxhealth's expertise in genetic and epigenetic testing to assess cancer risks and guide clinical decision-making. The contract does not have a set-aside designation.